Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates

Immunome, Inc. (IMNM) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.66. This compares to loss of $0.34 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 21.21%. A quarter ago, it was expected that this company would post a loss of $0.68 per share when it actually produced a loss of $0.84, delivering a surprise of -23.53%.Over the last four quarters, the company has surpasse ...